Cancer pain has a major impact on quality of life and clinical treatment of patients. Oral cancer patients rate pain as their worst symptom. Effective treatment of cancer pain remains a critical, unmet goal in cancer research. The proposed study will provide a molecular rationale for the development of mechanism-based therapeutic treatments to reduce oral cancer pain, and cancer pain in general, and allow patients to regain their function. Cancer cells and cancer-associated stromal cells secrete a complex ensemble of bioactive factors into their surroundings to promote cancer growth. A subset of these molecules also sensitizes nociceptors on nearby primary afferent sensory neurons, creating crosstalk among nociception and cancer growth pathways. The proposed research is a targeted sampling and proteomic approach to characterize pain-producing proteases and peptides within the cancer microenvironment. The experimental advantage of our intraoperative microdialysis collection technique is the direct sampling of cancer-associated proteins and peptides in vivo. The nociceptive effect of molecules will be evaluated and confirmed using a well- established cancer pain mouse model. Secreted proteases are promising, yet largely unexploited drug targets for manipulating the levels of pain-producing peptides. We hypothesize that selective inhibition of specific proteases will decrease levels of nociceptive peptides in the cancer environment and relieve cancer-associated pain. The data generated from the proposed studies will provide the molecular basis for an entirely new perspective with which to understand and treat cancer pain.
The Public Health relevance of this project is that successful completion will provide the foundation for a clinical trial based on the pain-producing molecules that we discover. Ultimately, this work could lead to improved treatment for cancer pain. PUBLIC HEALTH RELEVANCE STATEMENT The Public Health relevance of this project is that successful completion will provide the foundation for a clinical trial based on the pain-producing molecules that we discover. Ultimately, this work could lead to improved treatment for cancer pain.
|Viet, Chi T; Dang, Dongmin; Achdjian, Stacy et al. (2014) Decitabine rescues cisplatin resistance in head and neck squamous cell carcinoma. PLoS One 9:e112880|
|Viet, C T; Corby, P M; Akinwande, A et al. (2014) Review of preclinical studies on treatment of mucositis and associated pain. J Dent Res 93:868-75|
|Schmidt, Brian L; Kuczynski, Justin; Bhattacharya, Aditi et al. (2014) Changes in abundance of oral microbiota associated with oral cancer. PLoS One 9:e98741|
|Ye, Yi; Ono, Kentaro; Bernabé, Daniel G et al. (2014) Adenosine triphosphate drives head and neck cancer pain through P2X2/3 heterotrimers. Acta Neuropathol Commun 2:62|
|Schmidt, Brian L (2014) The neurobiology of cancer pain. Neuroscientist 20:546-62|
|Ye, Yi; Bae, Sam S; Viet, Chi T et al. (2014) IB4(+) and TRPV1(+) sensory neurons mediate pain but not proliferation in a mouse model of squamous cell carcinoma. Behav Brain Funct 10:5|
|Viet, Chi T; Dang, Dongmin; Ye, Yi et al. (2014) Demethylating drugs as novel analgesics for cancer pain. Clin Cancer Res 20:4882-93|
|Zhao, Peishen; Canals, Meritxell; Murphy, Jane E et al. (2013) Agonist-biased trafficking of somatostatin receptor 2A in enteric neurons. J Biol Chem 288:25689-700|
|Klingler, Diana; Hardt, Markus (2013) Protease- and acid-catalyzed labeling workflows employing (18)O-enriched water. J Vis Exp :e3891|
|Klingler, Diana; Hardt, Markus (2012) Profiling protease activities by dynamic proteomics workflows. Proteomics 12:587-96|
Showing the most recent 10 out of 13 publications